Sort   by:  
 Page size 
UnknownPotential value of ctDNA monitoring in metastatic HR + /HER2 - breast cancer: longitudinal ctDNA analysis in the phase Ib MONALEESASIA trial.
Not available
S-EPMC10426213 | biostudies-literature
UnknownIntrinsic Subtype and Overall Survival of Patients with Advanced HR+/HER2- Breast Cancer Treated with Ribociclib and ET: Correlative Analysis of MONALEESA-2, -3, -7.
Not available
S-EPMC10870119 | biostudies-literature
UnknownSafety and impact of dose reductions on efficacy in the randomised MONALEESA-2, -3 and -7 trials in hormone receptor-positive, HER2-negative advanced breast cancer.
Not available
S-EPMC8405616 | biostudies-literature
UnknownAdjuvant ribociclib plus nonsteroidal aromatase inhibitor therapy in patients with HR-positive/HER2-negative early breast cancer: 5-year follow-up of NATALEE efficacy outcomes and updated overall survival.
Not available
S-EPMC12684762 | biostudies-literature
UnknownRepurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
Not available
S-EPMC7727327 | biostudies-literature
UnknownAntibiotic Prescribing in Children Hospitalized With COVID-19 and Multisystem Inflammatory Syndrome in Spain: Prevalence, Trends, and Associated Factors.
Not available
S-EPMC8903467 | biostudies-literature
UnknownChronic kidney disease, cerebral blood flow, and white matter volume in hypertensive adults.
Not available
S-EPMC4818564 | biostudies-literature
UnknownEffect of Intensive Blood-Pressure Treatment on Patient-Reported Outcomes.
Not available
S-EPMC5706112 | biostudies-literature
UnknownComparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009-2015.
Not available
S-EPMC5740982 | biostudies-literature
UnknownMural Endocarditis: The GAMES Registry Series and Review of the Literature.
Not available
S-EPMC8572950 | biostudies-literature
Sort   by:  
 Page size